299 results
Histologic Features and Prevalence of Nonalcoholic Steatohepatitis (NASH). NASH is a potentially progressive type of nonalcoholic
of Nonalcoholic Steatohepatitis ... #Progression #HCC
Assessment of Nonalcoholic Steatohepatitis (NASH) Severity in Patients With Nonalcoholic Fatty
#Diagnosis #Pathology #NAFLD #NASH #Fibrosis #Staging
of Nonalcoholic Steatohepatitis
Liver Mass Differential Diagnosis
Solid:
 • Benign: Hepatic Hemangioma, Focal nodular hyperplasia, Hepatocellular adenoma, Regenerative nodules
 •
• Malignant: HCC ... Cystadenocarcinoma, Primary SCC
Erythrocytosis - Polycythemia Differential Diagnosis Algorithm

Elevated Hemoglobin:
 • Males: Hb > 16.5 g/dL/HCT ≥ 49%
 •
Hb > 16.5 g/dL/HCT ... : Hb > 16 g/dL/HCT ... Paraneoplastic (e.g., RCC ... , HCC, uterine fibroids
Tumor markers in clinical practice
Colorectal - CEA
Hepatocellular - AFP
Pancreatic - CA 19-9
Ovarian - CA 125
Breast -
Germ cell - AFP, HCG ... - CYFRA 21-1, SCC ... Trophoblastic - HCG
Hepatocellular Carcinoma (HCC) Surveillance and Management

#HCC #Hepatocellular #Carcinoma #Surveillance #Management #Treatment #Hepatology
Hepatocellular Carcinoma (HCC ... Management #HCC
Hepatic Masses on CT - Differential Diagnosis by CT Findings

Masses: Hemangioma, Adenoma, FNH, HCC, Fibrolamellar HCC,
Adenoma, FNH, HCC ... Fibrolamellar HCC
Pathogenesis of Nonalcoholic Steatohepatitis. Various factors, including inflammation, hyperinsulinemia or insulin resistance, and altered lipid homeostasis,
of Nonalcoholic Steatohepatitis
NAFLD / NASH Progression Timeline
Healthy Liver → NAFLD/NASH → 0.25-3.2%/year → Cirrhotic NASH → 0.3-2.6%/year →
0.3-2.6%/year → HCC ... Cirrhotic NASH → HCC
Hepatocellular Carcinoma (HCC) in Cirrhosis - Management Algorithm

Very early (0) - Single <2 cm, Preserved liver
Hepatocellular Carcinoma (HCC ... transplantable HCC ... Hepatocellular #Carcinoma #HCC